Skip to main content

Advertisement

Log in

Acute diclofenac treatment attenuates lipopolysaccharide-induced alterations to basic reward behavior and HPA axis activation in rats

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

Non-steroidal anti-inflammatory drugs (NSAIDs) counteract stress hormone and pro-inflammatory cytokine activation, and are being considered as therapeutics for Alzheimer’s and Parkinson’s disease, and multiple sclerosis. Previous data from our laboratory revealed that repeated treatment with the NSAID diclofenac attenuated lipopolysaccharide (LPS)-induced alterations to reward behavior, implicating a role for NSAIDs in alleviating depressive-like behavior.

Objectives

To extend these findings, we sought to determine whether acute treatment with diclofenac would attenuate LPS-induced alterations to basic reward behavior, as well as neuroendocrine and neuroimmune function.

Methods

Male, Wistar rats (n=8–9/grp) pressed a lever for sucrose pellet reward and after establishing a steady baseline were exposed to an injection of saline (1 ml/kg, SC) or diclofenac (2.5 mg/kg, SC) 30 min prior to a second injection of saline or LPS (20 μg/kg, IP).

Results

In saline pre-treated rats, LPS significantly reduced rate of sucrose pellet self-administration and total reinforcers obtained, suggestive of an anhedonia response. In addition, LPS increased corticosterone release, increased plasma intereleukin (IL)-1β release, increased IL-1β and IL-6 mRNA in hippocampus, increased corticotropin releasing hormone (CRH) mRNA in pituitary, and decreased CRH-1 mRNA in pituitary. Importantly, the behavioral and neuroendocrine effects, but not neuroimmune effects, produced by LPS were significantly attenuated in rats pre-treated with diclofenac.

Conclusions

These new data provide a comprehensive assessment of the acute effects of diclofenac on LPS exposure in rats and confirm a role for NSAIDs in attenuating endotoxin-induced anhedonia. Of particular importance, the data reveal that the observed effects are mediated via the hypothalamic pituitary adrenal axis at the level of the pituitary or above.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  • Allan SM, Rothwell NJ (2003) Inflammation in central nervous system injury. Philos Trans R Soc Lond B Biol Sci 358:1669–1677

    Article  CAS  PubMed  Google Scholar 

  • Anisman H, Merali Z (2002) Cytokines, stress, and depressive illness. Brain Behav Immun 16:513–524

    Article  CAS  PubMed  Google Scholar 

  • Asnis GM, De La Garza R II, Kohn SR, Reinus JF, Henderson M, Shah J (2003) IFN-induced depression: a role for NSAIDs. Psychopharmacol Bull 37:29–50

    Google Scholar 

  • Aubry JM, Turnbull AV, Pozzoli G, Rivier C, Vale W (1997) Endotoxin decreases corticotropin-releasing factor receptor 1 messenger ribonucleic acid levels in the rat pituitary. Endocrinology 138:1621–1626

    Article  CAS  PubMed  Google Scholar 

  • Bluthe RM, Crestani F, Kelley KW, Dantzer R (1992) Mechanisms of the behavioral effects of interleukin 1. Role of prostaglandins and CRF. Ann N Y Acad Sci 650:268–275

    CAS  PubMed  Google Scholar 

  • Buller KM, Xu Y, Day TA (1998) Indomethacin attenuates oxytocin and hypothalamic–pituitary–adrenal axis responses to systemic interleukin-1 beta. J Neuroendocrinol 10:519–528

    Article  CAS  PubMed  Google Scholar 

  • Castanon N, Bluthe RM, Dantzer R (2001) Chronic treatment with the atypical antidepressant tianeptine attenuates sickness behavior induced by peripheral but not central lipopolysaccharide and interleukin-1beta in the rat. Psychopharmacology 154:50–60

    Article  CAS  PubMed  Google Scholar 

  • Castanon N, Leonard BE, Neveu PJ, Yirmiya R (2002) Effects of antidepressants on cytokine production and actions. Brain Behav Immun 16:569–574

    Article  CAS  PubMed  Google Scholar 

  • Charlton BG (2000) The malaise theory of depression: major depressive disorder is sickness behavior and antidepressants are analgesic. Med Hypoth 54:126–130

    Article  CAS  Google Scholar 

  • Crestani F, Seguy F, Dantzer R (1991) Behavioural effects of peripherally injected interleukin-1: role of prostaglandins. Brain Res 542:330–335

    Article  CAS  PubMed  Google Scholar 

  • De La Garza R II (2004) Endotoxin- or pro-inflammatory cytokine-induced sickness behavior as an animal model of depression: focus on anhedonia. Neurosci Biobehav Rev (invited review, in press)

  • De La Garza R II, Fabrizio KR, Radoi GE, Vlad T, Asnis GM (2004a) The non-steroidal anti-inflammatory drug diclofenac sodium attenuates lipopolysaccharide-induced alterations to reward behavior and corticosterone release. Behav Brain Res 149:77–85

    Article  PubMed  Google Scholar 

  • De La Garza R II, Pedrosa E, Stearns C, Asnis GM (2004b) Chronic lypopolysaccharide results in tolerance to alterations to basic reward behavior, body weight, and food and water consumption. Biol Psychiatry 55(8), Supplement 1:59s

    Google Scholar 

  • Dunn AJ, Chuluyan HE (1992) The role of cyclo-oxygenase and lipoxygenase in the interleukin-1-induced activation of the HPA axis: dependence on the route of injection. Life Sci 51:219–225

    Article  CAS  PubMed  Google Scholar 

  • Dunn AJ, Swiergiel AH (2000) The role of cyclooxygenases in endotoxin- and interleukin-1-induced hypophagia. Brain Behav Immun 14:141–152

    Article  CAS  PubMed  Google Scholar 

  • Dunn AJ, Swiergiel AH (2001) The reductions in sweetened milk intake induced by interleukin-1 and endotoxin are not prevented by chronic antidepressant treatment. Neuroimmunomodulation 9:163–169

    Article  CAS  PubMed  Google Scholar 

  • Ekdahl CT, Claasen JH, Bonde S, Kokaia Z, Lindvall O (2003) Inflammation is detrimental for neurogenesis in adult brain. Proc Natl Acad Sci 100:13632–13637

    Article  CAS  PubMed  Google Scholar 

  • Gold PW, Chrousos G, Kellner C, Post R, Roy A, Augerinos P, Schulte H, Oldfield E, Loriaux DL (1984) Psychiatric implications of basic and clinical studies with corticotropin-releasing factor. Am J Psychiatry 141:619–627

    CAS  PubMed  Google Scholar 

  • Hart BL (1988) Biological basis of the behavior of sick animals. Neurosci Biobehav Rev 12:123–137

    CAS  PubMed  Google Scholar 

  • Holsboer F (2000) The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23:477–501

    Google Scholar 

  • Irwin M (2002) Psychoneuroimmunology of depression: clinical implications. Brain Behav Immun 16:1–16

    Article  PubMed  Google Scholar 

  • Johnson PM, Vogt SK, Burney MW, Muglia LJ (2002) COX-2 inhibition attenuates anorexia during systemic inflammation without impairing cytokine production. Am J Physiol Endocrinol Metab 282:E650–E656

    CAS  PubMed  Google Scholar 

  • Kelley KW, Bluthe RM, Dantzer R, Zhou JH, Shen WH, Johnson RW, Broussard SR (2003) Cytokine-induced sickness behavior. Brain Behav Immun 17:S112–S118

    Article  CAS  PubMed  Google Scholar 

  • Kent S, Bluthe RM, Kelley KW, Dantzer R (1992) Sickness behavior as a new target for drug development. Trends Pharmacol Sci 13:24–28

    Article  CAS  PubMed  Google Scholar 

  • Konsman JP, Parnet P, Dantzer R (2002) Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci 25:154–159

    Article  CAS  PubMed  Google Scholar 

  • Kronfol Z (2002) Immune dysregulation in major depression: a critical review of existing evidence. Int J Neuropsychopharmacol 5:333–343

    Article  CAS  PubMed  Google Scholar 

  • Kronfol Z, Remick DG (2000) Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry 157:683–694

    Article  CAS  PubMed  Google Scholar 

  • Kubera M, Lin AH, Kenis G, Bosmans E, van Bockstaele D, Maes M (2001) Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio. J Clin Psychopharmacol 21:199–206

    Google Scholar 

  • Lacroix S, Rivest S (1997) Functional circuitry in the brain of immune-challenged rats: partial involvement of prostaglandins. J Comp Neurol 387:307–324

    Article  CAS  PubMed  Google Scholar 

  • Langhans W, Savoldelli D, Weingarten S (1993) Comparison of the feeding responses to bacterial lipopolysaccharide and interleukin-1 beta. Physiol Behav 53:643–649

    Article  CAS  PubMed  Google Scholar 

  • Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H (2000) Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 22:370–379

    Article  PubMed  Google Scholar 

  • Larson SJ, Dunn AJ (2001) Behavioral effects of cytokines. Brain Behav Immun 15:371–387

    Article  CAS  PubMed  Google Scholar 

  • Laye S, Parnet P, Goujon E, Dantzer R (1994) Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. Brain Res Mol Brain Res 27:157–162

    Article  CAS  PubMed  Google Scholar 

  • Lenczowski MJ, Van Dam AM, Poole S, Larrick JW, Tilders FJ (1997) Role of circulating endotoxin and interleukin-6 in the ACTH and corticosterone response to intraperitoneal LPS. Am J Physiol 273:R1870–R1877

    CAS  PubMed  Google Scholar 

  • Leonard BE (2001) The immune system, depression and the action of antidepressants. Prog Neuropsychopharmacol Biol Psychiatry 25:767–780

    Article  CAS  PubMed  Google Scholar 

  • Licinio J, Wong ML (1999) The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Mol Psychiatry 4:317–327

    Article  CAS  PubMed  Google Scholar 

  • Licinio J, Kling MA, Hauser P (1998) Cytokines and brain function: relevance to interferon-alpha-induced mood and cognitive changes. Semin Oncol 25:30–38

    CAS  PubMed  Google Scholar 

  • Maes M (1999) Major depression and activation of the inflammatory response system. Adv Exp Med Biol 461:25–46

    CAS  PubMed  Google Scholar 

  • Malberg JE, Duman RS (2003) Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment. Neuropsychopharmacology 28:1562–1571

    Article  CAS  PubMed  Google Scholar 

  • Merali Z, Brennan K, Brau P, Anisman H (2003) Dissociating anorexia and anhedonia elicited by interleukin-1beta: antidepressant and gender effects on responding for “free chow” and “earned” sucrose intake. Psychopharmacology 165:413–418

    CAS  PubMed  Google Scholar 

  • Monje ML, Toda H, Palmer TD (2003) Inflammatory blockade restores adult hippocampal neurogenesis. Science 302:1760–1765

    Article  CAS  PubMed  Google Scholar 

  • Morimoto A, Murakami N, Nakamori T, Sakata Y, Watanabe T (1989) Possible involvement of prostaglandin E in development of ACTH response in rats induced by human recombinant interleukin-1. J Physiol 411:245–256

    CAS  PubMed  Google Scholar 

  • Nagano I, Takao T, Nanamiya W, Takemura T, Nishiyama M, Asaba K, Makino S, De Souza EB, Hashimoto K (1999) Differential effects of one and repeated endotoxin treatment on pituitary-adrenocortical hormones in the mouse: role of interleukin-1 and tumor necrosis factor-alpha. Neuroimmunomodulation 6:284–292

    Article  CAS  PubMed  Google Scholar 

  • National Institute of Mental Health (2002) Methods and welfare considerations in behavioral research with animals: report of a National Institutes of Health Workshop. In: Morrison AR, Evans HL, Ator NA, Nakamura RK (eds) NIH publication no. 02-5083. US Government Printing Office, Washington

    Google Scholar 

  • Nemeroff CB, Widerlov E, Bissette G, Walleus H, Karlsson I, Eklund K, Kilts CD, Loosen PT, Vale W (1984) Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 226:1342–1344

    CAS  PubMed  Google Scholar 

  • Niimi M, Wada Y, Sato M, Takahara J, Kawanishi K (1997) Effect of continuous intravenous injection of interleukin-6 and pretreatment with cyclooxygenase inhibitor on brain c-fos expression in the rat. Neuroendocrinology 66:47–53

    CAS  PubMed  Google Scholar 

  • Okamoto T (2002) NSAID zaltoprofen improves the decrease in body weight in rodent sickness behavior models: proposed new applications of NSAIDs. Int J Mol Med 9:369–372

    CAS  PubMed  Google Scholar 

  • Pariante CM, Miller AH (2001) Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psychiatry 49:391–404

    Article  CAS  PubMed  Google Scholar 

  • Parsadaniantz SM, Lebeau A, Duval P, Grimaldi B, Terlain B, Kerdelhue B (2000) Effects of the inhibition of cyclo-oxygenase 1 or 2 or 5-lipoxygenase on the activation of the hypothalamic–pituitary–adrenal axis induced by interleukin-1beta in the male rat. J Neuroendocrinol 12:766–773

    Article  CAS  PubMed  Google Scholar 

  • Preil J, Muller MB, Gesing A, Reul JM, Sillaber I, van Gaalen MM, Landgrebe J, Holsboer F, Stenzel-Poore M, Wurst W (2001) Regulation of the hypothalamic–pituitary–adrenocortical system in mice deficient for CRH receptors 1 and 2. Endocrinology 142:4946–4955

    Article  CAS  PubMed  Google Scholar 

  • Raison CL, Miller AH (2001) The neuroimmunology of stress and depression. Semin Clin Neuropsychiatr 6:277–294

    Article  CAS  Google Scholar 

  • Raison CL, Miller AH (2003) When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am J Psychiatry 160:1554–1565

    Article  PubMed  Google Scholar 

  • Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A, Pollmacher T (2001) Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 58:445–452

    Article  CAS  PubMed  Google Scholar 

  • Reichenberg A, Kraus T, Haack M, Schuld A, Pollmacher T, Yirmiya R (2002) Endotoxin-induced changes in food consumption in healthy volunteers are associated with TNF-alpha and IL-6 secretion. Psychoneuroendocrinology 27:945–956

    Article  CAS  PubMed  Google Scholar 

  • Ribot E, Lafon P, Ciofi P, Sarrieau A, Tramu G, Corio M (2003) Prostaglandins mediate lipopolysaccharide effects upon cholecystokinin and neurotensin phenotypes in neuroendocrine corticotropin-releasing hormone neurons: in situ hybridization evidence in the rat. Neuroscience 120:643–648

    Article  CAS  PubMed  Google Scholar 

  • Rivest S, Laflamme N (1995) Neuronal activity and neuropeptide gene transcription in the brains of immune-challenged rats. J Neuroendocrinol 7:501–525

    CAS  PubMed  Google Scholar 

  • Rivier CL, Grigoriadis DE, Rivier JE (2003) Role of corticotropin-releasing factor receptors type 1 and 2 in modulating the rat adrenocorticotropin response to stressors. Endocrinology 144:2396–2403

    Article  CAS  PubMed  Google Scholar 

  • Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, Weisstaub N, Lee J, Duman R, Arancio O, Belzung C, Hen R (2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301:805–809

    Article  CAS  PubMed  Google Scholar 

  • Smith GW, Aubry JM, Dellu F, Contarino A, Bilezikjian LM, Gold LH, Chen R, Marchuk Y, Hauser C, Bentley CA, Sawchenko PE, Koob GF, Vale W, Lee KF (1998) Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 20:1093–1102

    Article  CAS  PubMed  Google Scholar 

  • Swiergiel AH, Dunn AJ (2001) Cyclooxygenase 1 is not essential for hypophagic responses to interleukin-1 and endotoxin in mice. Pharmacol Biochem Behav 69:659–663

    Article  CAS  PubMed  Google Scholar 

  • Swiergiel AH, Dunn AJ (2002) Distinct roles for cyclooxygenases 1 and 2 in interleukin-1-induced behavioral changes. J Pharmacol Exp Ther 302:1031–1036

    Article  CAS  PubMed  Google Scholar 

  • Swiergiel AH, Smagin GN, Dunn AJ (1997) Influenza virus infection of mice induces anorexia: comparison with endotoxin and interleukin-1 and the effects of indomethacin. Pharmacol Biochem Behav 57:389–396

    Article  CAS  PubMed  Google Scholar 

  • Tilders FJ, DeRijk RH, Van Dam AM, Vincent VA, Schotanus K, Persoons JH (1994) Activation of the hypothalamus-pituitary-adrenal axis by bacterial endotoxins: routes and intermediate signals. Psychoneuroendocrinology 19:209–232

    Article  CAS  PubMed  Google Scholar 

  • Turnbull AV, Rivier C (1996) Corticotropin-releasing factor, vasopressin, and prostaglandins mediate, and nitric oxide restrains, the hypothalamic–pituitary–adrenal response to acute local inflammation in the rat. Endocrinology 137:455–463

    Article  CAS  PubMed  Google Scholar 

  • Turrin NP, Gayle D, Ilyin SE, Flynn MC, Langhans W, Schwartz GJ, Plata-Salaman CR (2001) Pro-inflammatory and anti-inflammatory cytokine mRNA induction in the periphery and brain following intraperitoneal administration of bacterial lipopolysaccharide. Brain Res Bull 54:443–453

    Article  CAS  PubMed  Google Scholar 

  • Uehara A, Ishikawa Y, Okumura T, Okamura K, Sekiya C, Takasugi Y, Namiki M (1989) Indomethacin blocks the anorexic action of interleukin-1. Eur J Pharmacol 170:257–260

    Article  CAS  PubMed  Google Scholar 

  • Wan W, Wetmore L, Sorensen CM, Greenberg AH, Nance DM (1994) Neural and biochemical mediators of endotoxin and stress-induced c-fos expression in the rat brain. Brain Res Bull 34:7–14

    Article  CAS  PubMed  Google Scholar 

  • Weidenfeld J, Yirmiya R (1996) Effects of bacterial endotoxin on the glucocorticoid feedback regulation of adrenocortical response to stress. Neuroimmunomodulation 3:352–357

    CAS  PubMed  Google Scholar 

  • Xu S, Guo S, Jiang X, Yin Q, Umezawa T, Hisamitsu T (2003) Effect of indomethacin on the c-fos expression in AVP and TH neurons in rat brain induced by lipopolysaccharide. Brain Res 966:13–18

    Article  CAS  PubMed  Google Scholar 

  • Yirmiya R (1996) Endotoxin produces a depressive-like episode in rats. Brain Res 711:163–174

    Article  CAS  PubMed  Google Scholar 

  • Yirmiya R, Weidenfeld J, Pollak Y, Morag M, Morag A, Avitsur R, Barak O, Reichenberg A, Cohen E, Shavit Y, Ovadia H (1999) Cytokines, “depression due to a general medical condition,” and antidepressant drugs. Adv Exp Med Biol 461:283–316

    CAS  PubMed  Google Scholar 

  • Yirmiya R, Pollak Y, Barak O, Avitsur R, Ovadia H, Bette M, Weihe E, Weidenfeld J (2001) Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents. Neuropsychopharmacology 24:531–544

    Google Scholar 

Download references

Acknowledgements

The authors wish to thank Gina-Elena Radoi for invaluable assistance with the initial gene expression work in this laboratory that gave rise to the data published in this report. The authors also wish to thank Dr. Myles Akabas (Department of Physiology and Biophysics) for the generous use of the Fluorchem gel capture and analysis system in his laboratory. Support for this research made possible through funds provided to RD by the Department of Psychiatry and Behavioral Sciences of the Albert Einstein College of Medicine, T. Byram Karasu, MD, Chair.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Richard De La Garza II.

Rights and permissions

Reprints and permissions

About this article

Cite this article

De La Garza, R., Asnis, G.M., Fabrizio, K.R. et al. Acute diclofenac treatment attenuates lipopolysaccharide-induced alterations to basic reward behavior and HPA axis activation in rats. Psychopharmacology 179, 356–365 (2005). https://doi.org/10.1007/s00213-004-2053-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-004-2053-x

Keywords

Navigation